0000947871-18-000587.txt : 20180720
0000947871-18-000587.hdr.sgml : 20180720
20180720102923
ACCESSION NUMBER: 0000947871-18-000587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180718
FILED AS OF DATE: 20180720
DATE AS OF CHANGE: 20180720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sukhtian Ghiath M.
CENTRAL INDEX KEY: 0001717441
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 18961724
MAIL ADDRESS:
STREET 1: 7TH CIRCLE, ZAHRAN ST.
STREET 2: ZAHRAN PLAZA BUILDING, 4TH FLOOR
CITY: AMMAN
STATE: M2
ZIP: 11844
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillai Arun Kumar
CENTRAL INDEX KEY: 0001717437
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 18961725
MAIL ADDRESS:
STREET 1: #30, "GALAXY," 1ST MAIN
STREET 2: J.P. NAGAR 3RD PHASE
CITY: BANGALORE
STATE: K7
ZIP: 560078
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GMS Tenshi Holdings Pte. Ltd
CENTRAL INDEX KEY: 0001716335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 18961726
BUSINESS ADDRESS:
STREET 1: 36 ROBINSON ROAD, #13-01 CITY HOUSE
CITY: SINGAPORE
STATE: U0
ZIP: 068877
BUSINESS PHONE: 962 6 582 7999
MAIL ADDRESS:
STREET 1: 36 ROBINSON ROAD, #13-01 CITY HOUSE
CITY: SINGAPORE
STATE: U0
ZIP: 068877
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncobiologics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 7 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 7 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
ownership.xml
X0306
4
2018-07-18
0
0001649989
Oncobiologics, Inc.
ONS
0001716335
GMS Tenshi Holdings Pte. Ltd
36 ROBINSON ROAD, #13-01 CITY HOUSE
SINGAPORE
U0
068877
SINGAPORE
1
0
1
0
0001717437
Pillai Arun Kumar
#30, 1ST MAIN
J.P. NAGAR 3RD PHASE
BANGALORE
K7
560078
INDIA
1
0
1
0
0001717441
Sukhtian Ghiath M.
7TH CIRCLE, ZAHRAN ST.
ZAHRAN PLAZA BUILDING, 4TH FLOOR
AMMAN
M2
11844
JORDAN
1
0
1
0
Series A Convertible Preferred Stock
2018-07-18
4
A
0
6526
A
Common Stock
986626
58735
D
Series A Convertible Preferred Stock
2018-07-18
4
D
0
58735
D
Common Stock
8879780
0
D
Series A-1 Convertible Preferred Stock
2018-07-18
4
A
0
58735
A
Common Stock
8879780
58735
D
Each share of Series A Convertible Preferred Stock ("Series A Preferred Stock") is convertible into shares of the Issuer's common stock, par value $0.01 per share ("Shares"), at any time at the election of the holder. The Series A Preferred Stock has no expiration date.
Represents shares of Series A Preferred Stock received by GMS Tenshi Holdings Pte. Limited ("GMS Tenshi") as a payment-in-kind dividend on previously purchased Series A Preferred Stock.
Shares of Series A Preferred Stock was exchanged on a one-for-one basis for shares of Series A-1 Convertible Preferred Stock ("Series A-1 Preferred Stock").
Each share of Series A-1 Preferred Stock is convertible into Shares at any time at the election of the holder. The Series A-1 Preferred Stock has no expiration date.
These securities are held of record by GMS Tenshi. Tenshi Life Sciences Private Limited ("Tenshi"), a private investment vehicle controlled by Arun Kumar Pillai ("Kumar"), and GMS Pharma (Singapore) Pte. Limited ("GMS Pharma"), a private investment company and wholly-owned subsidiary of GMS Holdings, are the 50:50 beneficial owners of GMS Tenshi, in which each of Tenshi and GMS Pharma owns 50% of the outstanding voting shares. Kumar, a natural person, is the holder of a controlling interest in Tenshi. Ghiath M. Sukhtian ("Ghiath Sukhtian"), a natural person, is the holder of a controlling interest in GMS Holdings, which is the holder of a controlling interest in GMS Pharma.
By virtue of the relationships described above in Footnote 3, Kumar and Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Tenshi noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. GMS Tenshi has designated four representatives to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
/s/ Faisal G. Sukhtian
2018-07-20
/s/ Arun Kumar Pillai
2018-07-20
/s/ Ghiath M. Sukhtian
2018-07-20